Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Neoadjuvant immunochemotherapy (NAIC) has been widely adopted for non-small cell lung cancer (NSCLC); however, reliable tools for postoperative disease-free survival (DFS) risk stratification remain lacking. We developed and validated a habitat radiomics–clinicopathological fusion model, termed the Neoadjuvant Lung Joint Clustering (NeoLung-JC) model, for postoperative DFS stratification and prediction in patients with NSCLC who underwent surgery after NAIC.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.